Zoetis Inc.
Capitalisation boursière
$30.2B
Rang mondial
#303
Sommet historique
$97.5B
2021-12-31
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 17% of the 367 companies we track (globally).
- Equivalent to 0.1% of United States's GDP (2025 data).
- Just above: #302 Copart, Inc. ($30.5B)
- Just below: #304 Zscaler, Inc. ($29.8B)
- Best year: 2019 (+56%). Worst year: 2026 (-42%).
Zoetis Inc. Financial Breakdown (FY 2025)
Source: Yahoo Finance — ZTS annual filings (2025) →$9.5B revenue · $3.6B operating income · $2.7B net income
- ●Operating margin: 38.0% on $9.5B in revenue.
- ●R&D is 7.4% of revenue ($0.7B).
- ●Net income margin: 28.2% — $2.7B in profit.
- ●Free cash flow: $2.3B (24.1% of revenue).
Cost / Operating Expenses
Total operating expenses $5.9B
Total
$5.7B
Capital Expenditures
$0.6B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$2.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
À propos de Zoetis Inc.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.
Historique de la capitalisation boursière de Zoetis Inc. (2026–2026)
Zoetis Inc. vs Sector Peers by Market Cap
Comparer Zoetis Inc.
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $30.2B | #303(↓58) | -42.3% |
| 2025 | $52.3B | #245(↓51) | -21.8% |
| 2024 | $66.8B | #194(↓55) | -16.6% |
| 2023 | $80.2B | #139(↑13) | +35.9% |
| 2022 | $59.0B | #152(↓49) | -39.5% |
| 2021 | $97.5B | #103(↑22) | +48.3% |
| 2020 | $65.8B | #125(↑9) | +25.8% |
| 2019 | $52.3B | #134(↑24) | +55.7% |
| 2018 | $33.6B | #158(↑43) | +19.4% |
| 2017 | $28.1B | #201(↑6) | +35.5% |
| 2016 | $20.7B | #207 | +12.6% |
| 2015 | $18.4B | #207(↑9) | +12.2% |
| 2014 | $16.4B | #216(↑5) | +32.8% |
| 2013 | $12.4B | #221 |
Autres entreprises du secteur Santé
FAQ
What is Zoetis Inc.'s market cap?
Zoetis Inc. (ZTS) has a market capitalization of $30.2B, making it the #303 largest company in the world by market cap.
What was Zoetis Inc.'s highest market cap?
Zoetis Inc.'s all-time high market cap was $97.5B, reached in 2021-12-31. Its highest rank was #103 in 2021.
What sector is Zoetis Inc. in?
Zoetis Inc. is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry. It is based in United States.
How has Zoetis Inc.'s market cap changed over time?
Zoetis Inc. has been tracked since 2026. Its market cap has grown by 0% from $30.2B in 2026 to $30.2B today.